References
- YoungRPHopkinsRJChristmasTCOPD prevalence is increased in lung cancer, independent of age, sex and smoking historyEur Respir J20093438038619196816
- de TorresJPMarinJMCasanovaCLung cancer in patients with chronic obstructive pulmonary disease – incidence and predicting factorsAm J Respir Crit Care Med201118491391921799072
- PurdueMPGoldLJarvholmBImpaired lung function and lung cancer incidence in a cohort of Swedish construction workersThorax200762515616928722
- YoungRPHopkinsRJCOPD and lung cancer linked at a molecular genetic levelChest201114026626721729901
- BentwichIAvnielAKarovYIdentification of hundreds of conserved and nonconserved human microRNAsNat Genet20053776677015965474
- BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell200411628129714744438
- SayedDAbdellatifMMicroRNAs in development and diseasePhysiol Rev20119182788721742789
- LandiMTZhaoYRotunnoMMicroRNA expression differentiates histology and predicts survival of lung cancerClin Cancer Res20101643044120068076
- YanaiharaNCaplenNBowmanEUnique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell2006918919816530703
- HayashitaYOsadaHTatematsuYA polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferationCancer Res2005659628963216266980
- ChinLJRatnerELengSA SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer riskCancer Res2008688535854018922928
- GaoYHeYDingJAn insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3′ untranslated region confers risk for hepatocellular carcinomaCarcinogenesis2009302064206919917630
- ChenKSongFCalinGAPolymorphisms in microRNA targets: a gold mine for molecular epidemiologyCarcinogenesis2008291306131118477647
- ChristensenBCMoyerBJAvissarMA let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancersCarcinogenesis2009301003100719380522
- GrazianoFCanestrariELoupakisFGenetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecanPharmacogenomics J20101045846420177422
- WangWYChienYCWongYKEffects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinomaHead Neck20123466366621688344
- LiZHPanXMHanBWA let-7 binding site polymorphism rs712 in the KRAS 3′ UTR is associated with an increased risk of gastric cancerTumour Biol2013343159316323729275
- PunturieriASzaboECroxtonTLLung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated researchJ Natl Cancer Inst200910155455919351920
- LiangSHeLZhaoXMicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancerPLoS One20116e1840921533124
- TakamizawaJKonishiHYanagisawaKReduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survivalCancer Res2004643753375615172979
- ChangSSJiangWWSmithIMicroRNA alterations in head and neck squamous cell carcinomaInt J Cancer20081232791279718798260
- JohnsonSMGrosshansHShingaraJRAS is regulated by the let-7 microRNA familyCell200512063564715766527
- HeXYChenJXZhangZThe let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude miceJ Cancer Res Clin Oncol20101361023102820033209
- KranenburgOThe KRAS oncogene: past, present, and futureBiochim Biophys Acta20051756818216269215
- BosJLFearonERHamiltonSRPrevalence of ras gene mutations in human colorectal cancersNature19873272932973587348
- BoughdadyISKinsellaARHaboubiNYK-ras gene mutations in adenomas and carcinomas of the colonSurg Oncol199212752821341261
- AkaoYNakagawaYNaoeTlet-7 microRNA functions as a potential growth suppressor in human colon cancer cellsBiol Pharm Bull20062990390616651716
- ChinLJRatnerELengSA SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer riskCancer Res2008688535854018922928
- ParanjapeTHeneghanHLindnerRA 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysisLancet Oncol20111237738621435948
- HollestelleAPelletierCHooningMPrevalence of the variant allele rs61764370 T.G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer familiesBreast Cancer Res Treat2011128798420676756
- PharoahPDPalmieriRTRamusSJThe role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingClin Cancer Res2011173742375021385923
- CollinsMAPascaMMKras as a key oncogene and therapeutic target in pancreatic cancerFront Physiol2014440724478710
- KimMChenXChinLJExtensive sequence variation in the 3′ untranslated region of the KRAS gene in lung and ovarian cancer casesCell Cycle2014131030104024552817